Bausch Health Companies
(TSX) BHC
Bausch Health Companies Financials at a Glance
Market Cap
$2.77B
Revenue (TTM)
$8.54B
Net Income (TTM)
$155.28M
EPS (TTM)
$0.56
P/E Ratio
13.38
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$7.50
Volume
128,862
Open
$7.51
Price
$7.50
Volume
128,862
Open
$7.51
Previous Close
$7.50
Daily Range
$7.42 - $7.56
52-Week Range
$5.91 - $11.97
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$7.50
Volume
128,862
Open
$7.51
Previous Close
$7.50
Daily Range
$7.42 - $7.56
52-Week Range
$5.91 - $11.97
BHC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bausch Health Companies
Industry
Pharmaceuticals
Sector
Health CareEmployees
20,300
CEO
Thomas J. Appio
Website
www.bauschhealth.comHeadquarters
Laval, QC H7L 4A8, CA
BHC Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
20%
Net Income Margin
2%
Return on Equity
0%
Return on Capital
9%
Return on Assets
1%
Earnings Yield
7.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.77B
Shares Outstanding
370.56M
Volume
128.86K
Short Interest
0.00%
Avg. Volume
510.86K
Financials (TTM)
Gross Profit
$6.36B
Operating Income
$2.22B
EBITDA
$3.45B
Operating Cash Flow
$1.38B
Capital Expenditure
$403.95M
Free Cash Flow
$974.77M
Cash & ST Invst.
$1.32B
Total Debt
$21.21B
Bausch Health Companies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.84B
+10.9%
Gross Profit
$1.79B
-2.3%
Gross Margin
63.02%
N/A
Market Cap
$2.77B
N/A
Market Cap/Employee
$133.90K
N/A
Employees
20,700
N/A
Net Income
$113.72M
-222.3%
EBITDA
$1.02B
+20.1%
Quarterly Fundamentals
Net Cash
$19.88B
+2.7%
Accounts Receivable
$2.35B
+9.7%
Inventory
$1.63B
+1.9%
Long Term Debt
$20.91B
+10.4%
Short Term Debt
$296.46M
-88.9%
Return on Assets
0.59%
N/A
Return on Invested Capital
9.34%
N/A
Free Cash Flow
$402.53M
-18.5%
Operating Cash Flow
$495.92M
-17.5%